{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:49:59Z","timestamp":1750157399727,"version":"3.40.3"},"publisher-location":"Cham","reference-count":60,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319020952"},{"type":"electronic","value":"9783319020969"}],"license":[{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-319-02096-9_24","type":"book-chapter","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T03:02:24Z","timestamp":1384830144000},"page":"361-371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paediatric Liver Disease"],"prefix":"10.1007","author":[{"given":"Giorgina","family":"Mieli-Vergani","sequence":"first","affiliation":[]},{"given":"Rodrigo","family":"Liberal","sequence":"additional","affiliation":[]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"key":"24_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354:54\u201366.","journal-title":"N Engl J Med"},{"key":"24_CR2","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1002\/hep.21059","volume":"43","author":"MP Manns","year":"2006","unstructured":"Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology. 2006;43:S132\u201344.","journal-title":"Hepatology"},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrgastro.2011.69","volume":"8","author":"G Mieli-Vergani","year":"2011","unstructured":"Mieli-Vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol. 2011;8:320\u20139.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1089-3261(02)00018-1","volume":"6","author":"D Vergani","year":"2002","unstructured":"Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis. 2002;6:727\u201337.","journal-title":"Clin Liver Dis"},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","volume":"41","author":"D Vergani","year":"2004","unstructured":"Vergani D, Alvarez F, Bianchi FB, Cancado EL, Mackay IR, Manns MP, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41:677\u201383.","journal-title":"J Hepatol"},{"key":"24_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997;25:541\u20137.","journal-title":"Hepatology"},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jaut.2004.11.009","volume":"24","author":"R Oettinger","year":"2005","unstructured":"Oettinger R, Brunnberg A, Gerner P, Wintermeyer P, Jenke A, Wirth S. Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis. J Autoimmun. 2005;24:79\u201384.","journal-title":"J Autoimmun"},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1053\/jhep.2002.32092","volume":"35","author":"Y Ma","year":"2002","unstructured":"Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002;35:658\u201364.","journal-title":"Hepatology"},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","volume":"322","author":"P Ahonen","year":"1990","unstructured":"Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322:1829\u201336.","journal-title":"N Engl J Med"},{"key":"24_CR10","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.3748\/wjg.14.3301","volume":"14","author":"EL Krawitt","year":"2008","unstructured":"Krawitt EL. Clinical features and management of autoimmune hepatitis. World J Gastroenterol. 2008;14:3301\u20135.","journal-title":"World J Gastroenterol"},{"key":"24_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.bpg.2011.10.007","volume":"25","author":"G Mieli-Vergani","year":"2011","unstructured":"Mieli-Vergani G, Vergani D. Autoimmune liver diseases in children\u2014what is different from adulthood? Best Pract Res Clin Gastroenterol. 2011;25:783\u201395.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, et al. Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001;33:544\u201353.","journal-title":"Hepatology"},{"key":"24_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/hep.22073","volume":"47","author":"R Abdalian","year":"2008","unstructured":"Abdalian R, Dhar P, Jhaveri K, Haider M, Guindi M, Heathcote EJ. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology. 2008;47:949\u201357.","journal-title":"Hepatology"},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/gut.2003.031732","volume":"53","author":"PT Donaldson","year":"2004","unstructured":"Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut. 2004;53:599\u2013608.","journal-title":"Gut"},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jhep.2004.06.001","volume":"41","author":"PT Donaldson","year":"2004","unstructured":"Donaldson PT. Genetics of autoimmune and viral liver diseases; understanding the issues. J Hepatol. 2004;41:327\u201332.","journal-title":"J Hepatol"},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","volume":"130","author":"Y Ma","year":"2006","unstructured":"Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006;130:868\u201382.","journal-title":"Gastroenterology"},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1053\/jhep.2001.24562","volume":"33","author":"L Fainboim","year":"2001","unstructured":"Fainboim L, Canero Velasco MC, Marcos CY, Ciocca M, Roy A, Theiler G, et al. Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis. Hepatology. 2001;33:1512\u20137.","journal-title":"Hepatology"},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/hep.510300611","volume":"30","author":"M Pando","year":"1999","unstructured":"Pando M, Larriba J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, et al. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology. 1999;30:1374\u201380.","journal-title":"Hepatology"},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(85)90348-4","volume":"2","author":"D Vergani","year":"1985","unstructured":"Vergani D, Wells L, Larcher VF, Nasaruddin BA, Davies ET, Mieli-Vergani G, et al. Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis. Lancet. 1985;2:294\u20138.","journal-title":"Lancet"},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0168-8278(02)80564-5","volume":"36","author":"JA Underhill","year":"2002","unstructured":"Underhill JA, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Different immunogenetic background in autoimmune hepatitis type 1, type 2 and autoimmune sclerosing cholangitis. J Hepatol. 2002;36:156.","journal-title":"J Hepatol"},{"key":"24_CR21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bpg.2011.09.009","volume":"25","author":"R Liberal","year":"2011","unstructured":"Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2011;25:653\u201364.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998\u20131005.","journal-title":"Hepatology"},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u201376.","journal-title":"Hepatology"},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/hep.510240309","volume":"24","author":"GV Gregorio","year":"1996","unstructured":"Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, et al. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. Hepatology. 1996;24:520\u20133.","journal-title":"Hepatology"},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2249.1998.00574.x","volume":"112","author":"GV Gregorio","year":"1998","unstructured":"Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol. 1998;112:471\u20136.","journal-title":"Clin Exp Immunol"},{"key":"24_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/lt.20352","volume":"11","author":"A Dhawan","year":"2005","unstructured":"Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson\u2019s disease in children: 37-year experience and revised King\u2019s score for liver transplantation. Liver Transpl. 2005;11:441\u20138.","journal-title":"Liver Transpl"},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/01.mcg.0000139072.38580.a0","volume":"38","author":"SJ Cotler","year":"2004","unstructured":"Cotler SJ, Kanji K, Keshavarzian A, Jensen DM, Jakate S. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J Clin Gastroenterol. 2004;38:801\u20134.","journal-title":"J Clin Gastroenterol"},{"key":"24_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-0029-1233529","volume":"29","author":"G Mieli-Vergani","year":"2009","unstructured":"Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis. 2009;29:297\u2013306.","journal-title":"Semin Liver Dis"},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","volume":"1","author":"M Manns","year":"1987","unstructured":"Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde KH. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet. 1987;1:292\u20134.","journal-title":"Lancet"},{"key":"24_CR31","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","volume":"355","author":"I Wies","year":"2000","unstructured":"Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buschenfelde KH, et al. Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis. Lancet. 2000;355:1510\u20135.","journal-title":"Lancet"},{"key":"24_CR32","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","volume":"52","author":"DJ Gassert","year":"2007","unstructured":"Gassert DJ, Garcia H, Tanaka K, Reinus JF. Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis. Dig Dis Sci. 2007;52:2433\u20137.","journal-title":"Dig Dis Sci"},{"key":"24_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1517\/14656566.2011.524206","volume":"12","author":"D Vergani","year":"2011","unstructured":"Vergani D, Mieli-Vergani G. Pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother. 2011;12:607\u201313.","journal-title":"Expert Opin Pharmacother"},{"key":"24_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/01.mpg.0000304456.84552.13","volume":"46","author":"AR Ferreira","year":"2008","unstructured":"Ferreira AR, Roquete ML, Toppa NH, de Castro LP, Fagundes ED, Penna FJ. Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2008;46:65\u201370.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"24_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/01.mpg.0000239735.87111.ba","volume":"43","author":"N Kerkar","year":"2006","unstructured":"Kerkar N, Annunziato RA, Foley L, Schmeidler J, Rumbo C, Emre S, et al. Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr. 2006;43:629\u201334.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"24_CR36","first-page":"438a","volume":"44","author":"B Samaroo","year":"2006","unstructured":"Samaroo B, Samyn M, Buchanan C, Mieli-Vergani G. Long-term daily oral treatment with prednisolone in children with autoimmune liver disease does not affect final adult height. Hepatology. 2006;44:438a.","journal-title":"Hepatology"},{"key":"24_CR37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2223\/1371","volume":"81","author":"AR Ferreira","year":"2005","unstructured":"Ferreira AR, Roquete ML, Penna FJ, Toppa NH, Castro LP. [Type 1 autoimmune hepatitis in children and adolescents: assessment of immunosuppressive treatment withdrawal]. J Pediatr (Rio J). 2005;81:343\u20138.","journal-title":"J Pediatr (Rio J)"},{"key":"24_CR38","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193\u2013213.","journal-title":"Hepatology"},{"key":"24_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/clpt.1989.119","volume":"46","author":"L Lennard","year":"1989","unstructured":"Lennard L, Van Loon JA, Weinshilboum RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther. 1989;46:149\u201354.","journal-title":"Clin Pharmacol Ther"},{"key":"24_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1517\/14740338.7.3.319","volume":"7","author":"AJ Czaja","year":"2008","unstructured":"Czaja AJ. Safety issues in the management of autoimmune hepatitis. Expert Opin Drug Saf. 2008;7:319\u201333.","journal-title":"Expert Opin Drug Saf"},{"key":"24_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00005176-200209000-00032","volume":"35","author":"C Rumbo","year":"2002","unstructured":"Rumbo C, Emerick KM, Emre S, Shneider BL. Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report. J Pediatr Gastroenterol Nutr. 2002;35:391\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"24_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","volume":"30","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Ciocca M, Canero-Velasco C, Ramonet M, de Davila MT, Cuarterolo M, et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol. 1999;30:222\u20137.","journal-title":"J Hepatol"},{"key":"24_CR43","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","volume":"139","author":"MP Manns","year":"2010","unstructured":"Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010;139:1198\u2013206.","journal-title":"Gastroenterology"},{"key":"24_CR44","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/S0168-8278(11)60031-7","volume":"54","author":"M Woynarowski","year":"2011","unstructured":"Woynarowski M, Nemeth A, Baruch Y, Koletzko S, Melter M, Rodeck B, et al. Budesonide vs prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr. (In press).","journal-title":"J Hepatol"},{"key":"24_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/jhep.2002.30991","volume":"35","author":"MA Heneghan","year":"2002","unstructured":"Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology. 2002;35:7\u201313.","journal-title":"Hepatology"},{"key":"24_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","volume":"51","author":"MM Aw","year":"2009","unstructured":"Aw MM, Dhawan A, Samyn M, Bargiota A, Mieli-Vergani G. Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol. 2009;51:156\u201360.","journal-title":"J Hepatol"},{"key":"24_CR47","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1053\/gast.2001.27965","volume":"121","author":"SA Mitchell","year":"2001","unstructured":"Mitchell SA, Bansi DS, Hunt N, Von Bergmann K, Fleming KA, Chapman RW. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology. 2001;121:900\u20137.","journal-title":"Gastroenterology"},{"key":"24_CR48","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009;50:808\u201314.","journal-title":"Hepatology"},{"key":"24_CR49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/0891693021000056721","volume":"35","author":"GV Gregorio","year":"2002","unstructured":"Gregorio GV, McFarlane B, Bracken P, Vergani D, Mieli-Vergani G. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity. 2002;35:515\u20139.","journal-title":"Autoimmunity"},{"key":"24_CR50","first-page":"555A","volume":"46","author":"AHM Scalori","year":"2007","unstructured":"Scalori AHM, Hadzic N, Vergani D, Mieli-Vergani G. Outcome and survival in childhood onset autoimmune sclerosing cholangitis and autoimmune hepatitis: a 13 years follow-up study. Hepatology. 2007;46:555A.","journal-title":"Hepatology"},{"key":"24_CR51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cgh.2011.10.028","volume":"10","author":"R Liberal","year":"2012","unstructured":"Liberal R, Longhi MS, Grant CR, Mieli-Vergani G, Vergani D. Autoimmune hepatitis after liver transplantation. Clin Gastroenterol Hepatol. 2012;10:346\u201353.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"24_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","volume":"351","author":"N Kerkar","year":"1998","unstructured":"Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet. 1998;351:409\u201313.","journal-title":"Lancet"},{"key":"24_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00005176-200102000-00007","volume":"32","author":"HM Hernandez","year":"2001","unstructured":"Hernandez HM, Kovarik P, Whitington PF, Alonso EM. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr. 2001;32:131\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"24_CR54","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","volume":"71","author":"P Gupta","year":"2001","unstructured":"Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation. 2001;71:664\u20138.","journal-title":"Transplantation"},{"key":"24_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/00007890-200107270-00018","volume":"72","author":"S Andries","year":"2001","unstructured":"Andries S, Casamayou L, Sempoux C, Burlet M, Reding R, Bernard Otte J, et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation. 2001;72:267\u201372.","journal-title":"Transplantation"},{"key":"24_CR56","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0041-1345(00)02826-8","volume":"33","author":"M Spada","year":"2001","unstructured":"Spada M, Bertani A, Sonzogni A, Petz W, Riva S, Torre G, et al. A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis. Transplant Proc. 2001;33:1747\u20138.","journal-title":"Transplant Proc"},{"key":"24_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","volume":"78","author":"A Miyagawa-Hayashino","year":"2004","unstructured":"Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S, et al. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation. 2004;78:128\u201335.","journal-title":"Transplantation"},{"key":"24_CR58","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1600-6143.2006.01717.x","volume":"7","author":"RS Venick","year":"2007","unstructured":"Venick RS, McDiarmid SV, Farmer DG, Gornbein J, Martin MG, Vargas JH, et al. Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis. Am J Transplant. 2007;7:955\u201363.","journal-title":"Am J Transplant"},{"key":"24_CR59","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.26756","volume":"34","author":"MA Heneghan","year":"2001","unstructured":"Heneghan MA, Portmann BC, Norris SM, Williams R, Muiesan P, Rela M, et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology. 2001;34:464\u201370.","journal-title":"Hepatology"},{"key":"24_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/jhep.2002.31167","volume":"35","author":"M Salcedo","year":"2002","unstructured":"Salcedo M, Vaquero J, Banares R, Rodriguez-Mahou M, Alvarez E, Vicario JL, et al. Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology. 2002;35:349\u201356.","journal-title":"Hepatology"}],"container-title":["Liver Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-02096-9_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T21:50:43Z","timestamp":1675115443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-02096-9_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,29]]},"ISBN":["9783319020952","9783319020969"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-02096-9_24","relation":{},"subject":[],"published":{"date-parts":[[2013,10,29]]},"assertion":[{"value":"29 October 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}